Ignite Creation Date:
2024-05-06 @ 3:05 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04514523
Status:
COMPLETED
Last Update Posted:
2023-01-06
First Post:
2020-08-12
Brief Title:
QBSAfe A Novel Approach to Diabetes Management Focused on Quality of Life Burden of Treatment Social Integration and Avoidance of Future Events
Sponsor:
Yale University
Organization:
Yale University
Study Overview
Official Title:
QBSAfe A Novel Approach to Diabetes Management Focused on Quality of Life Burden of Treatment Social Integration and Avoidance of Future Events
Status:
COMPLETED
Status Verified Date:
2022-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
QBSAfe
Brief Summary:
The purpose of this study is to co-develop a toolkit known as the QBSAfe toolkit with patients family caregivers and clinicians that focuses on palliating symptoms alleviating burden of treatment facilitating social connections and optimizing treatment safety for patients with diabetes mellitus
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 19-004560 | OTHER | Mayo | httpsreporternihgovquickSearch1R21AG061427-01 |
| 1R21AG061427-01 | NIH | None | None |